Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03729817 · ClinicalTrials.gov registry record · NA
REstoring Flow by REvascularization With Submaximal Angioplasty in Hemodynamic IntraCranial Atherosclerotic Stenosis
A NA study, sponsored by Case Western Reserve University.
- Not yet
- Registry status
- NA
- Development phase
- 159
- Enrollment target
NCT03729817 is a NA study that has not yet begun recruiting, run by Case Western Reserve University. The registered enrollment target is 159 participants.
The verdict
NCT03729817, a NA study, has not yet begun recruiting, sponsored by Case Western Reserve University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 159 participants
- Enrollment target
Study Summary
By assessing the safety and durability of an endovascular intervention, this study will justify and inform the design of a subsequent seamless feasibility/pivotal trial aimed at the treatment of intracranial atherosclerotic stenosis (ICAS), an entity which carries a high risk of stroke despite existing medical therapies, and has no other treatment options. Given the global burden of ICAS as a leading cause of stroke, there is a high potential for public health impact not just in the U.S., but world-wide.
Interventions
- DEVICE Submaximal balloon angioplasty
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 159 participants |
| Start Date | 2027-10 |
| Est. Completion | 2032-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03729817
The ClinicalTrials.gov registry entry for NCT03729817 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 159 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Western Reserve University, which has 141 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Submaximal balloon angioplasty is the first listed.
NCT03729817 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03729817 about?
NCT03729817 is a clinical study titled "REstoring Flow by REvascularization With Submaximal Angioplasty in Hemodynamic IntraCranial Atherosclerotic Stenosis". By assessing the safety and durability of an endovascular intervention, this study will justify and inform the design of a subsequent seamless feasibility/pivotal trial aimed at the treatment of intracranial atherosclerotic stenosis (ICAS), an entity which carries a high risk of stroke despite exist...
What is the current status of trial NCT03729817?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 159 participants. The study started on 2027-10. Estimated completion is 2032-10-31.
What interventions are being tested in trial NCT03729817?
The interventions under investigation include: Submaximal balloon angioplasty (DEVICE).
Who is sponsoring clinical trial NCT03729817?
This trial is sponsored by Case Western Reserve University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.